lunes, 16 de noviembre de 2026

Bladder cancer immunotherapy from CG Oncology reduced risk of tumor recurrence The study results could change the way physicians treat certain patients with bladder cancer

https://www.statnews.com/2026/11/16/bladder-cancer-immunotherapy-reduced-tumor-recurrence-cg-oncology/ By Adam FeuersteinNov. 16, 2026 Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only newsletter about the crossroads of drug development, business, Wall Street, and biotechnology.

No hay comentarios:

Publicar un comentario